前沿论文｜CELL INTELLIGENCE

Itolizumab regulates activating and inhibitory signals on effector cells, improving their cytotoxicity against CD318+ tumor cell lines.

PubMed 2025/05/05 发表Front ImmunolQ1 · IF 7（JCR 2025）

52.1分

★★★☆☆

站内排序·非疗效

The immune-related gene CD5 is a prognostic biomarker associated with the tumor microenvironment of breast cancer.

PubMed 2025/01/13 发表Discov OncolQ3 · IF 2.8（JCR 2025）

34.6分

★☆☆☆☆

站内排序·非疗效

前沿论文 2